Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

As you navigate the challenges of prostate cancer and erectile dysfunction, remember that you are not alone. With advances in ...